{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:34:00Z","timestamp":1782826440202,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Chongqing Adverse Drug Reaction Monitoring Center","award":["Y0120240008"],"award-info":[{"award-number":["Y0120240008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00210-026-05108-z","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T02:18:14Z","timestamp":1772072294000},"page":"11905-11921","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adverse drug events and toxicological mechanisms of esketamine: a study based on US Food and Drug Administration Adverse Event Reporting System and network toxicology analysis"],"prefix":"10.1007","volume":"399","author":[{"given":"Lu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengxu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shipeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"issue":"4","key":"5108_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afae061","volume":"53","author":"B Almodibeg","year":"2024","unstructured":"Almodibeg B, Forget P (2024) Challenges of acute pain management in older patients. Age Ageing 53(4):afae06","journal-title":"Age Ageing"},{"issue":"23","key":"5108_CR2","first-page":"2833","volume":"292","author":"C Barbui","year":"2004","unstructured":"Barbui C (2004) Antidepressants and the risk of suicidal behaviors. JAMA 292(23):2833\u20132834","journal-title":"JAMA"},{"issue":"4","key":"5108_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002280050466","volume":"54","author":"A Bate","year":"1998","unstructured":"Bate A, Lindquist M, Edwards IR et al (1998) A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 54(4):315\u2013321","journal-title":"Eur J Clin Pharmacol"},{"key":"5108_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","volume":"102","author":"C Bj\u00f6rkholm","year":"2016","unstructured":"Bj\u00f6rkholm C, Monteggia LM (2016) BDNF-a key transducer of antidepressant effects. Neuropharmacology 102:72\u201379","journal-title":"Neuropharmacology"},{"issue":"5","key":"5108_CR5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1176\/appi.ajp.2011.11020215","volume":"168","author":"D Brent","year":"2011","unstructured":"Brent D (2011) Nonsuicidal self-injury as a predictor of suicidal behavior in depressed adolescents. Am J Psychiatry 168(5):452\u2013454","journal-title":"Am J Psychiatry"},{"issue":"6","key":"5108_CR6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S1087-0792(03)90005-0","volume":"7","author":"KJ Brower","year":"2003","unstructured":"Brower KJ (2003) Insomnia, alcoholism and relapse. Sleep Med Rev 7(6):523\u2013539","journal-title":"Sleep Med Rev"},{"issue":"7","key":"5108_CR7","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1176\/appi.ajp.2018.17060720","volume":"175","author":"CM Canuso","year":"2018","unstructured":"Canuso CM, Singh JB, Fedgchin M et al (2018) Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study. Am J Psychiatry 175(7):620\u2013630","journal-title":"Am J Psychiatry"},{"issue":"2","key":"5108_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/ijms19020341","volume":"19","author":"CH Chiu","year":"2018","unstructured":"Chiu CH, Chyau CC, Chen CC et al (2018) Erinacine A-enriched Hericium erinaceus mycelium produces antidepressant-like effects through modulating BDNF\/PI3K\/Akt\/GSK-3\u03b2 signaling in mice. Int J Mol Sci 19(2):341","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5108_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/(SICI)1099-1166(199602)11:2<157::AID-GPS304>3.0.CO;2-S","volume":"11","author":"MG Cole","year":"1996","unstructured":"Cole MG, Yaffe MJ (1996) Pathway to psychiatric care of the elderly with depression. Int J Geriatr Psychiatry 11(2):157\u2013161","journal-title":"Int J Geriatr Psychiatry"},{"issue":"12","key":"5108_CR10","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S2215-0366(19)30292-5","volume":"6","author":"IA Cristea","year":"2019","unstructured":"Cristea IA, Naudet F (2019) US food and drug administration approval of esketamine and brexanolone. Lancet Psychiatry 6(12):975\u2013977","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"5108_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","volume":"75","author":"EJ Daly","year":"2018","unstructured":"Daly EJ, Singh JB, Fedgchin M et al (2018) Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial. JAMA Psychiat 75(2):139\u2013148","journal-title":"JAMA Psychiat"},{"issue":"9","key":"5108_CR12","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1001\/jamapsychiatry.2019.1189","volume":"76","author":"EJ Daly","year":"2019","unstructured":"Daly EJ, Trivedi MH, Janik A et al (2019) Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial. JAMA Psychiat 76(9):893\u2013903","journal-title":"JAMA Psychiat"},{"issue":"3","key":"5108_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s40263-020-00699-4","volume":"34","author":"T Doherty","year":"2020","unstructured":"Doherty T, Wajs E, Melkote R et al (2020) Cardiac safety of esketamine nasal spray in treatment-resistant depression: results from the clinical development program. CNS Drugs 34(3):299\u2013310","journal-title":"CNS Drugs"},{"issue":"7","key":"5108_CR14","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/ijnp\/pyaa034","volume":"23","author":"M Dold","year":"2020","unstructured":"Dold M, Bartova L, Kasper S (2020) Treatment response of add-on esketamine nasal spray in resistant major depression in relation to add-on second-generation antipsychotic treatment. Int J Neuropsychopharmacol 23(7):440\u2013445","journal-title":"Int J Neuropsychopharmacol"},{"issue":"9","key":"5108_CR15","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1001\/jamaneurol.2023.2309","volume":"80","author":"H Elser","year":"2023","unstructured":"Elser H, Horv\u00e1th-Puh\u00f3 E, Gradus JL et al (2023) Association of early-, middle-, and late-life depression with incident dementia in a Danish cohort. JAMA Neurol 80(9):949\u2013958","journal-title":"JAMA Neurol"},{"issue":"1","key":"5108_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000510703","volume":"90","author":"C Gastaldon","year":"2020","unstructured":"Gastaldon C, Raschi E, Kane JM et al (2020) Post-marketing safety concerns with esketamine: a disproportionality analysis of spontaneous reports submitted to the FDA adverse event reporting system. Psychother Psychosom 90(1):41\u201348","journal-title":"Psychother Psychosom"},{"key":"5108_CR17","doi-asserted-by":"crossref","unstructured":"GBD 2019 Mental Disorders Collaborators. (2022). Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry 9(2):137\u2013150","DOI":"10.1016\/S2215-0366(21)00395-3"},{"key":"5108_CR18","doi-asserted-by":"publisher","first-page":"107300","DOI":"10.1016\/j.phrs.2024.107300","volume":"206","author":"N Guo","year":"2024","unstructured":"Guo N, Wang X, Xu M et al (2024) PI3K\/AKT signaling pathway: molecular mechanisms and therapeutic potential in depression. Pharmacol Res 206:107300","journal-title":"Pharmacol Res"},{"issue":"3","key":"5108_CR19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1176\/appi.ajp.20230025","volume":"180","author":"MK Jha","year":"2023","unstructured":"Jha MK, Mathew SJ (2023) Pharmacotherapies for treatment-resistant depression: how antipsychotics fit in the rapidly evolving therapeutic landscape. Am J Psychiatry 180(3):190\u2013199","journal-title":"Am J Psychiatry"},{"issue":"1","key":"5108_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41386-023-01632-1","volume":"49","author":"JN Johnston","year":"2024","unstructured":"Johnston JN, Kadriu B, Kraus C et al (2024) Ketamine in neuropsychiatric disorders: an update. Neuropsychopharmacology 49(1):23\u201340","journal-title":"Neuropsychopharmacology"},{"key":"5108_CR21","doi-asserted-by":"crossref","unstructured":"Kessler RC, Berglund P, Demler O et al (2003) National comorbidity survey replication. the epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289(23):3095\u20133105","DOI":"10.1001\/jama.289.23.3095"},{"key":"5108_CR22","doi-asserted-by":"publisher","first-page":"107085","DOI":"10.1016\/j.phrs.2024.107085","volume":"201","author":"S Ledesma-Corvi","year":"2024","unstructured":"Ledesma-Corvi S, Jornet-Plaza J, G\u00e1lvez-Melero L et al (2024) Novel rapid treatment options for adolescent depression. Pharmacol ReS 201:107085","journal-title":"Pharmacol ReS"},{"key":"5108_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ejphar.2015.05.036","volume":"762","author":"L Luo","year":"2015","unstructured":"Luo L, Liu XL, Li J et al (2015) Macranthol promotes hippocampal neuronal proliferation in mice via BDNF-TrkB-PI3K\/Akt signaling pathway. Eur J Pharmacol 762:357\u2013363","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"5108_CR24","doi-asserted-by":"publisher","first-page":"R310","DOI":"10.1016\/S0960-9822(02)00825-4","volume":"12","author":"AK McAllister","year":"2002","unstructured":"McAllister AK (2002) BDNF. Curr Biol 12(9):R310","journal-title":"Curr Biol"},{"issue":"12","key":"5108_CR25","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1176\/appi.ajp.2021.21060653r","volume":"178","author":"RS McIntyre","year":"2021","unstructured":"McIntyre RS (2021) Ketamine and esketamine for treatment-resistant depression: response to Reus, Mattes, and Schatzberg. Am J Psychiatry 178(12):1130\u20131132","journal-title":"Am J Psychiatry"},{"issue":"1","key":"5108_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41380-018-0017-5","volume":"24","author":"Y Milaneschi","year":"2019","unstructured":"Milaneschi Y, Simmons WK, van Rossum EFC et al (2019) Depression and obesity: evidence of shared biological mechanisms. Mol Psychiatry 24(1):18\u201333","journal-title":"Mol Psychiatry"},{"issue":"6","key":"5108_CR27","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1001\/jamainternmed.2014.1053","volume":"174","author":"M Miller","year":"2014","unstructured":"Miller M, Swanson SA, Azrael D et al (2014) Antidepressant dose, age, and the risk of deliberate self-harm. JAMA Intern Med 174(6):899\u2013909","journal-title":"JAMA Intern Med"},{"issue":"13","key":"5108_CR28","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1056\/NEJMp1311047","volume":"370","author":"R Mojtabai","year":"2014","unstructured":"Mojtabai R (2014) Diagnosing depression in older adults in primary care. N Engl J Med 370(13):1180\u20131182","journal-title":"N Engl J Med"},{"issue":"15","key":"5108_CR29","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.3390\/jcm10153377","volume":"10","author":"A Mosio\u0142ek","year":"2021","unstructured":"Mosio\u0142ek A, Mosio\u0142ek J, Jakima S (2021) Effects of antidepressant treatment on neurotrophic factors (BDNF and IGF-1) in patients with major depressive disorder (MDD). J Clin Med 10(15):3377","journal-title":"J Clin Med"},{"key":"5108_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/annonc\/mdz440","volume":"30","author":"SE Nunnery","year":"2019","unstructured":"Nunnery SE, Mayer IA (2019) Management of toxicity to isoform \u03b1-specific PI3K inhibitors. Ann Oncol 30:21\u201326. https:\/\/doi.org\/10.1093\/annonc\/mdz440","journal-title":"Ann Oncol"},{"issue":"23","key":"5108_CR31","doi-asserted-by":"publisher","first-page":"13098","DOI":"10.3390\/ijms252313098","volume":"25","author":"S Pardossi","year":"2024","unstructured":"Pardossi S, Fagiolini A, Cuomo A (2024) Variations in BDNF and their role in the neurotrophic antidepressant mechanisms of ketamine and esketamine: a review. Int J Mol Sci 25(23):13098","journal-title":"Int J Mol Sci"},{"issue":"9","key":"5108_CR32","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.1016\/j.apsb.2025.07.030","volume":"15","author":"F Ren","year":"2025","unstructured":"Ren F, Wei J, Chen Q et al (2025) Artificial intelligence-driven multi-omics approaches in Alzheimer\u2019s disease: Progress, challenges, and future directions. Acta Pharm Sin B 15(9):4327\u20134385","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"5108_CR33","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/wps.20770","volume":"19","author":"CF Reynolds","year":"2020","unstructured":"Reynolds CF (2020) Optimizing personalized management of depression: the importance of real-world contexts and the need for a new convergence paradigm in mental health. World Psychiatry 19(3):266\u2013268","journal-title":"World Psychiatry"},{"issue":"12","key":"5108_CR34","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S1470-2045(18)30608-9","volume":"19","author":"JE Salem","year":"2018","unstructured":"Salem JE, Manouchehri A, Moey M et al (2018) Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study. Lancet Oncol 19(12):1579\u20131589","journal-title":"Lancet Oncol"},{"issue":"8","key":"5108_CR35","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nn1742","volume":"9","author":"L Sosa","year":"2006","unstructured":"Sosa L et al (2006) IGF-1 receptor is essential for the establishment of hippocampal neuronal polarity. Nat Neurosci 9(8):993\u2013995","journal-title":"Nat Neurosci"},{"issue":"S2","key":"5108_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.eurpsy.2013.09.113","volume":"28","author":"M Tournier","year":"2013","unstructured":"Tournier M, Etchepare F, Sanglier T (2013) Access to mental health care in depressed older patients. Eur Psychiatry 28(S2):44","journal-title":"Eur Psychiatry"},{"issue":"1","key":"5108_CR37","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0091-3057(92)90667-5","volume":"43","author":"TW Uhde","year":"1992","unstructured":"Uhde TW, Malloy LC, Slate SO (1992) Fearful behavior, body size, and serum IGF-I levels in nervous and normal pointer dogs. Pharmacol Biochem Behav 43(1):263\u2013269","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"5108_CR38","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0006-3223(02)01338-0","volume":"52","author":"J Un\u00fctzer","year":"2002","unstructured":"Un\u00fctzer J (2002) Diagnosis and treatment of older adults with depression in primary care. Biol Psychiatry 52(3):285\u2013292","journal-title":"Biol Psychiatry"},{"key":"5108_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1432759","volume":"15","author":"R Xiong","year":"2024","unstructured":"Xiong R, Lei J, Wang L et al (2024) Efficient analysis of adverse drug events and toxicological mechanisms of newly marketed drugs by integrating pharmacovigilance and network toxicology: selumetinib as an example. Front Pharmacol 15:1432759","journal-title":"Front Pharmacol"},{"issue":"12","key":"5108_CR40","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1002\/ptr.6489","volume":"33","author":"T Yan","year":"2019","unstructured":"Yan T, Sun Y, Xiao F et al (2019) Schisandrae chinensis Fructus inhibits behavioral deficits induced by sleep deprivation and chronic unpredictable mild stress via increased signaling of brain-derived neurotrophic factor. Phytother Res 33(12):3177\u20133190","journal-title":"Phytother Res"},{"key":"5108_CR41","doi-asserted-by":"publisher","first-page":"1329436","DOI":"10.3389\/fphar.2024.1329436","volume":"15","author":"X Yang","year":"2024","unstructured":"Yang X, Chen D (2024) Comparing the adverse effects of ketamine and esketamine between genders using FAERS data. Front Pharmacol 15:1329436","journal-title":"Front Pharmacol"},{"issue":"1","key":"5108_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/aps.2010.184","volume":"32","author":"H Yu","year":"2011","unstructured":"Yu H, Chen ZY (2011) The role of BDNF in depression on the basis of its location in the neural circuitry. Acta Pharmacol Sin 32(1):3\u201311","journal-title":"Acta Pharmacol Sin"},{"key":"5108_CR43","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jad.2024.08.123","volume":"368","author":"X Zang","year":"2024","unstructured":"Zang X, Zhang J, Hu J et al (2024) Electroconvulsive therapy combined with esketamine improved depression through PI3K\/AKT\/GLT-1 pathway. J Affect Disord 368:282\u2013294","journal-title":"J Affect Disord"},{"issue":"5","key":"5108_CR44","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jaac.2023.05.031","volume":"63","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Lan X, Wang C et al (2024) Effect of repeated intravenous esketamine on adolescents with major depressive disorder and suicidal ideation: a randomized active-placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 63(5):507\u2013518","journal-title":"J Am Acad Child Adolesc Psychiatry"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05108-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05108-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05108-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:05:22Z","timestamp":1781514322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05108-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["5108"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05108-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"9 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}